Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: BRCA1 patent infringement lawsuits

This article was originally published in The Gray Sheet

Executive Summary

BRCA1 patent infringement lawsuits: Myriad Genetics sues OncorMed in Salt Lake City, Utah federal court, alleging that the firm infringes Myriad's patent No. 5,693,473, entitled "17q-Linked Breast and Ovarian Cancer Susceptibility Gene." Myriad filed the suit Dec. 2, the same day the company was issued the patent. The complaint follows OncorMed's Nov. 17 lawsuit alleging that Myriad infringes its own BRCA1-related patent ("The Gray Sheet" Dec. 1, I&W-6). Both firms market tests for detecting mutations in the BRCA1 and BRCA2 genes...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009218

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel